Defining the Path Forward: Guidance for Laboratory Medicine Guidelines.
The National Academy of Clinical Biochemistry (NACB) has developed consensus-based guidelines for the laboratory evaluation and monitoring of patients with specified disorders for two decades. In 1997, the NACB recognized the need to standardize the process of guideline development and promulgated its first Standard Operating Procedure (SOP) for this purpose. In 2010, the American Association of Clinical Chemistry (AACC) and NACB created the Evidence-Based Laboratory Medicine Committee (EBLMC). Among other roles, this group was given responsibility to provide oversight of clinical practice guideline development in accordance with SOP guidance and using currently accepted good practices. In 2011, the U.S. Institute of Medicine (IOM) published two reports of relevance: 'Clinical Practice Guidelines We Can Trust' and 'Finding What Works in Health Care - Standards for Systematic Reviews.' These reports were created as part of a response to a legislative mandate from the U.S. Congress requesting that steps be taken to implement recommendations from lOM's report on 'Knowing What Works in Health Care' (2008). The latest revision of the laboratory medicine practice guidelines (LMPG) SOP was in part driven by these reports. NACB continues to develop LMPGs at a rate of roughly one per year through standard processes detailed in its 2014 revision of the SOP. This article describes the NACB and EBLMC experience in developing LMPGs with a focus on the evolution and use of the latest SOP. AACC and NACB have established a solid track record in collaboratively working with many clinical societies and professional organizations on clinical practice guideline development. Presently, three LMPG's are in various stages of development and all with the collaboration of other clinical/professional groups. The practices and tools being used for current LMPGs in progress are also highlighted in the context of the challenges that presently exist for effective clinical practice guideline development in the U.S.
Department of Pathology, Loyola University Health System, A Member of Trinity Health , Maywood, IL, USA.
Stephen E
SE
Kahn
Department of Pathology, University of Texas Southwestern Medical Center and Children's Medical Center , Dallas, TX, USA.
Patricia M
PM
Jones
Calgary Laboratory Services; and Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary , Calgary, AB, Canada.
Alex C
AC
Chin
Department of Pathology, University of Maryland School of Medicine , Baltimore, MD, USA.
Robert H
RH
Christenson
AGREE II; evidence-based laboratory medicine; evidence-based medicine; laboratory management practice guideline; standard operating procedure
Clin Chem. 2011 Jun;57(6):e1-e47
21617152
J Pain Palliat Care Pharmacother. 2008;22(4):306-11
21923316
Clin Chem. 2011 Jun;57(6):793-8
21617153
CMAJ. 2010 Dec 14;182(18):E839-42
20603348
Circulation. 2007 Apr 3;115(13):e356-75
17384331
Am J Prev Med. 2001 Apr;20(3 Suppl):21-35
11306229
Clin Chem. 2012 Oct;58(10):1426-37
22879395
Clin Chem. 2009 May;55(5):853-5
19299540
Clin Chem. 2013 Feb;59(2):446-7
23243222
Clin Chem. 2007 Apr;53(4):545-6
17384002